Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 286859011000036118 | lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 286860011000036117 | epinephrine 100 microgram / 20 mL + lidocaine hydrochloride 200 mg / 20 mL injection, 20 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | Is a | lidocaine hydrochloride 1% (200 mg/20 mL) injection, vial | true | Inferred relationship | Some | ||
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | Is a | medicinal product unit of use | false | Inferred relationship | Some | ||
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | Is a | lidocaine + adrenaline (epinephrine) | true | Inferred relationship | Some | ||
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | has intended active ingredient | adrenaline (epinephrine) | true | Inferred relationship | Some | 1346668696 | |
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | has Australian BoSS | adrenaline (epinephrine) | true | Inferred relationship | Some | 1346668696 | |
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 1568174232 | |
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | has Australian BoSS | lidocaine hydrochloride | true | Inferred relationship | Some | 1568174232 | |
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1568174233 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xylocaine 1% with Adrenaline 1 in 200 000 injection, 20 mL vial | Is a | True | lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | Inferred relationship | Some | |
| lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, 5 x 20 mL vials | has MPUU | True | lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR